Regulatory responses to over-the-counter codeine analgesic misuse in Australia, New Zealand and the United Kingdom

Australian and New Zealand Journal of Public Health

Volumn 37, Issue 5, 2013, Pages 483-488

  Tobin, Claire L ^a   Dobbin, Malcolm ^b   McAvoy, Brian ^c  

^a MONASH UNIVERSITY   (Australia)

^b Mental Health   (Australia)

^c Capri Hospital   (New Zealand)

Author keywords

analgesics; codeine; drug policy; misuse; non medical use; over the counter drugs

Indexed keywords

CODEINE; NARCOTIC ANALGESIC AGENT; NON PRESCRIPTION DRUG; ANALGESIC AGENT;

ADDICTION; ADVISORY COMMITTEE; AUSTRALIA; DRUG CONTROL; GOVERNMENT REGULATION; HUMAN; NEW ZEALAND; POLICY; PRODUCT SAFETY; PUBLIC HEALTH; UNITED KINGDOM; ARTICLE; DRUG POLICY; MISUSE; NON-MEDICAL USE; OVER-THE-COUNTER DRUGS;

ADVISORY COMMITTEES; ANALGESICS, OPIOID; AUSTRALIA; CODEINE; CONSUMER PRODUCT SAFETY; DRUG AND NARCOTIC CONTROL; GOVERNMENT REGULATION; GREAT BRITAIN; HUMANS; NEW ZEALAND; NONPRESCRIPTION DRUGS; PUBLIC HEALTH; PUBLIC POLICY; SUBSTANCE-RELATED DISORDERS;

ANALGESICS; CODEINE; DRUG POLICY; MISUSE; NON-MEDICAL USE; OVER-THE-COUNTER DRUGS;

EID: 84885464023     PISSN: 13260200     EISSN: None     Source Type: Journal    
DOI: 10.1111/1753-6405.12099     Document Type: Article

References (52)

1. National Drugs and Poisons Schedule Committee. Record of Reasons 52nd Meeting 19-20 February 2008. Canberra (AUST): Commonwealth Department of Health and Ageing, Therapeutic Goods Administration; 2008.
2. Medicines Classification Committee. Minutes of the December 2007 Medicines Classification Committee Meeting. Wellington (NZ): New Zealand Medicines and Medical Devices Safety Authority; 2007.
3. Reay G,. An Inquiry into Physical Dependence and Addiction to Prescription and Over-the-Counter Medication. London (UK): All-Party Parliamentary Drug Misuse Group, 2007-2008 Parliamentary Session; 2008.
4. Analgesic Expert Group. Therapeutic Guidelines: Analgesic. Version 5. Updated September 2007. Melbourne (AUST): Therapeutic Guidelines; 2011.
5. New Drugs. Aust Prescriber. 2002; 25 (4): 98.
6. Dutch MJ,. Nurofen Plus misuse: an emerging cause of perforated gastric ulcer. Med J Aust. 2008; 188 (1): 56-7.
7. Frei MY, Nielsen S, Dobbin MDH, Tobin CL,. Serious morbidity associated with misuse of over-the-counter codeine-ibuprofen analgesics: a series of 27 cases. Med J Aust. 2010; 193 (5): 294-6.
8. Ernest D, Chia M, Corallo CE,. Profound hypokalaemia due to Nurofen Plus and Red Bull misuse. Crit Care Resusc. 2010; 12 (2): 109-10.
9. Ng JL, Morgan DJR, Loh NKM, Gan SK, Coleman PL, Ong GSY, et al,. Life-threatening hypokalaemia associated with ibuprofen-induced renal tubular acidosis. Med J Aust. 2011; 194 (6): 313-16.
10. Page CB, Wilson PA, Foy A, Downes MA, Whyte IM, Isbister GK,. Life-threatening hypokalaemia associated with ibuprofen-induced renal tubular acidosis. Med J Aust. 2011; 194 (11): 613-14.
11. McDonough MA,. Misuse of codeine-containing combination analgesics. Med J Aust. 2011; 194 (9): 486.
12. Karamatic R, Croese J, Roche E,. Serious morbidity associated with misuse of over-the-counter codeine-ibuprofen analgesics. Med J Aust. 2011; 195 (9): 516.
13. Mallett A, Lynch M, John GT, Healy H, Lust K,. Ibuprofen-related renal tubular acidosis in pregnancy. Obstet Med. 2011; 4: 122.
14. Robinson GM, Robinson S, McCarthy P, Cameron C,. Misuse of over-the-counter codeine-containing analgesics: dependence and other adverse effects. N Z Med J. 2010; 123 (1317): 59-64.
15. McAvoy BR, Dobbin MDH, Tobin CL,. Over-the-counter codeine analgesic misuse and harm: characteristics of cases in Australia and New Zealand. N Z Med J. 2011; 124 (1346): 29-33.
16. Evans C, Chalmers-Watson TA, Gearry RB,. Combination NSAID-codeine preparations and gastrointestinal toxicity. N Z Med J. 2010; 123 (1324): 92-3.
17. Chetty R, Baoku Y, Mildner R, Banerjee A, Vallance D, Haddon A, et al,. Severe hypokalaemia and weakness due to Nurofen misuse. Ann Clin Biochem. 2003; 40: 422-3.
18. Lambert AP, Close C,. Life-threatening hypokalaemia from abuse of Nurofen Plus. J R Soc Med. 2005; 98: 21.
19. Good B, Ford C,. Over the counter drugs can be highly addictive. BMJ. 2007; 334: 917-8.
20. Dyer B, Martin J, Mitchell J, Sauven N, Gazzard B,. Hypokalaemia in ibuprofen and codeine phosphate abuse. Int J Clin Pract. 2004; 58 (11): 1061-2.
21. Ter A, Salha R, Vadamalai V, Soper C,. Ibuprofen codeine combination precipitating severe hypokalaemia in a patient with pre-existing type 1 renal tubular acidosis (letter). NDT Plus. 2008; 4: 270-1.
22. Blackstock M, Lee A,. Hypokalaemia and renal tubular acidosis due to abuse of Nurofen Plus. Case Rep Crit Care. 2012: 3. doi:10.11552012141505.
23. Nielsen S, Cameron J, Pahoki S,. Over the Counter Codeine Dependence. Melbourne (AUST): Turning Point Alcohol and Drug Centre, 2010.
24. Australian Institute of Health and Welfare. 2010 National Drug Strategy Household Survey Report. Canberra (AUST): AIHW; 2011.
25. Australian Instritute of Health and Welfare. 2010 National Drug Strategy Household Survey Report. Canberra (AUST): AIHW; 2011.
26. Nicholas R, Lee N, Roche A,. Pharmaceutical Drug Misuse Problems in Australia: Complex Issues, Balanced Responses. Adelaide (AUST): Flinders University, National Centre for Education and Training on Addiction; 2011.
27. International Narcotics Control Board. INCB Annual Report Press Release: Urgent Action is Needed Against the Growing Problem of Prescription Drug Abuse [Internet]. Vienna (AUT): INCB; 2010 [cited 2012 Oct 7]. Available from: http://www.incb.org/incb/en/press-releases-2010.html.
28. World Health Organization. Ensuring Balance in National Policies on Controlled Substances: Guidance for Availability and Accessibility of Controlled Substances. Geneva (CHE): WHO; 2011.
29. Peterson GM,. Selecting nonprescription analgesics. Am J Ther. 2005; 12 (1): 67-79.
30. ComLaw. Therapeutic Goods Act 1989. Canberra (AUST): Commonwealth of Australia; 1989.
31. New Zealand Legislation. Medicines Act 1981. Wellington (NZ): New Zealand Parliamentary Counsel Office; 1981.
32. United Kingdom Legislation. Medicines Act 1968. London (UK): Her Majesty Government; 1968.
33. National Drugs and Poisons Schedule Committee. Record of Reasons, 56th Meeting 2009 June 16-17. Canberra (AUST): Commonwealth Department of Health and Ageing, Therapeutic Goods Administration; 2009.
34. National Drugs and Poisons Schedule Committee. Record of Reasons, 53rd Meeting 2008 June 17-18. Canberra (AUST): Commonwealth Department of Health and Ageing, Therapeutic Goods Administration; 2008.
35. National Drugs and Poisons Schedule Committee. Record of Reasons, 54th Meeting 2008 October 14-15. Canberra (AUST): Commonwealth Department of Health and Ageing, Therapeutic Goods Administration; 2008.
36. National Drugs and Poisons Schedule Committee. Record of Reasons, 55th Meeting 2009 February 17-18. Canberra (AUST): Commonwealth Department of Health and Ageing, Therapeutic Goods Administration; 2009.
37. Therapeutic Goods Administration. Codeine Rescheduling-Information for Sponsors [Internet]. Canberra (AUST): Commonwealth Department of Health and Ageing; 2010 [cited 2010 Oct 12]. Available from: http://www.webcitation.org/ 5yvt07xzm.
38. Medicines and Healthcare Products Regulatory Agency. MHRA Public Assessment Report. Codeine and dihydrocodeine-containing medicines: minimising the risk of addiction. London (UK): MHRA; 2009.
39. Medicines and Healthcare Products Regulatory Agency. Dear Healthcare Professional Letter: Updated Advice on Non-prescription Medicines Containing Codeine or Dihydrocodeine (DHC) [Internet]. London (UK): MHRA; 2009 [cited 2010 Oct 1]. Available from: http://www.webcitation.org/5z82aAg4Y.
40. Medicines Classification Committee. Minutes of the December 2007 Medicines Classification Committee Meeting [Internet]. Wellington (NZ): New Zealand Medicines and Medical Devices Safety Authority; 2007 [cited 2010 Oct 1]. Available from: http://www.medsafe.govt.nz/profs/class/mccMin14Dec2007.htm.
41. Medicines Classification Committee. Minutes of the May 2009 Medicines Classification Committee Meeting. Wellington (NZ): New Zealand Medicines and Medical Devices Safety Authority; 2009 [cited 2010 Oct 1]. Available from: http://www.medsafe.govt.nz/profs/class/mccMin14May09.htm.
42. Medicines Classification Committee. Minutes of the November 2009 Medicines Classification Committee Meeting. Wellington (NZ): New Zealand Medicines and Medical Devices Safety Authority; 2009 [cited 2010 Oct 1]. Available from: http://www.medsafe.govt.nz/profs/class/mccMin03Nov2009.htm.
43. Medicines Classification Committee. Minutes of the November 2008 Medicines Classification Committee Meeting. Wellington (NZ): Medicines and Medical Devices Safety Authority; 2008 [cited 2010 Oct 1]. Available from: http://www.medsafe.govt.nz/profs/class/mccMin25Nov2008.htm.
44. Kriebel D, Tickner J,. Reenergizing public health through precaution. Am J Public Health. 2001; 91 (9): 1351-5.
45. Stosic R, Dunagan F, Palmer H, Fowler T, Adams I,. Responsible self-medication: perceived risks and benefits of over-the-counter analgesic use. Int J Pharm Pract. 2011; 19 (4): 236-45.
46. Nielsen S, Cameron J, Lee N,. Characteristics of a non-treatment seeking sample of over-the-counter codeine users: implications for intervention and prevention. J Opioid Manag. 2011; 7 (5): 363-70.
47. Nielsen S, Tobin C, Dobbin M,. OTC codeine: Examining the evidence for and against. Aust Pharm. 2012; 31 (3): 236-40.
48. Hazell L, Shakir S,. Under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2006; 29 (5): 385-96.
49. Committee on Safety of Medicines. Availability of Codeine and Dihydrocodeine Containing OTC Analgesics. London (UK): MHRA; 2005.
50. National Drugs and Poisons Schedule Committee. Poisons Standard 2008. Canberra (AUST): Commonwealth Department of Health and Ageing, Therapeutic Goods Administration; 2008.
51. Department of Health and Ageing. Poisons Standard 2010. Canberra (AUST): Commonwealth of Australia; 2010.
52. New Zealand Medicines and Medical Devices Safety Authority. Alerts/Letters: Changes to Classification and Labelling Requirements for Codeine-containing Medicines [Internet]. Wellington (NZ): MEDSAFE; 2010 [cited 2010 Oct 1]. Available from: http://www.webcitation.org/5z86HKQnj.